Drug Discovery

#Drug delivery #Drug development #Drug discovery #Drug repurposing #Microbiome #Mucoadhesive drug delivery #Pharmaceutical industry #Synthetic biology

New podcast: Outside the box thinking for drug discovery success

This is the latest episode of the free DDW narrated podcast, “Outside the box thinking for drug discovery success”, which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Stanford researchers construct the most complete synthetic microbiome, … Read More

#News

PEGS Europe posters
#Antibodies #Antibody discovery workflow #Biologics #Drug discovery #Events #PEGS Europe 2023 #Protein engineering

Reflecting on PEGS Europe 2023 

DDW’s Megan Thomas attended PEGS Europe 2023 in Lisbon, Portugal, from Tuesday 14 November to Thursday 16 November 2023. Here, she shares insight from the annual biologics technology meeting.   Scientific tracks and presentations  Antibody-based cancer therapies   The first presentation attended in the antibody-based cancer therapies… Read More

#Exclusive Content

New appointments
#Appointment #Drug discovery #New appointment

Drug discovery’s senior appointments for Q4

Keep up to speed with the sector’s top executive appointments with DDW’s regular recruitment round-up. Kimryn Rathmell  has been chosen as the 17th director of the National Cancer Institute (NCI), bringing her experience as leader of the Department of Medicine at the Vanderbilt University Medical Center… Read More

#News

#Biomedical research #Drug development #Meet the Researcher #Pathology #Virscio

Meet the researcher: Jennifer Cann, Virscio 

DDW’s Megan Thomas speaks to Jennifer Cann, Director of Pathology at Virscio, a company solving human health challenges through biomedical research.  MT: Can you provide a top line summary of your research? JC: As Virscio’s Director of Pathology, I provide exploratory and translational pathology support for… Read More

#Exclusive Content #Opinion

Flower of Oldenlandia monanthos
#Drug discovery #Plant-based #Proteins #University of Bath

Can a plant-based discovery pave the way for new drug treatments?

Scientists at the University of Bath have developed a way of joining up the head and tail of a protein, making it more stable and easier to get into cells. This new tool may help researchers develop new pharmaceuticals in a cleaner, greener, and less expensive way. Drug treatments often… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cloud computing #Drug discovery #Machine learning

Future-proofing drug discovery through flexible platforms

Dr Robert Scoffin, CEO, and Tim Cheeseright, Chief Technology Officer, at Cresset, explore the importance of flexible solutions for future-proofing drug discovery.  The ability to respond to changes in patient and customer needs is a constant challenge in the pharmaceutical industry, with ever-evolving requirements influencing even… Read More

#Exclusive Content

#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug discovery #eBook #Gene therapy

DDW eBook: The latest innovations in cell and gene therapy

Hailed as a revolution in the treatment of many diseases, cell and gene therapy is the fastest growing area of therapeutics. This eBook, ‘Cell & Gene Therapy: The advances and innovation’, provides a comprehensive overview of the latest innovations in cell and gene therapies, where the… Read More

#News

Two scientists working in a lab
#Antibody discovery workflow #Biotherapeutics #Cell line development #Cell lines #Drug development #Large molecules

Advancements in upstream CLD for enhanced biotherapeutics production

This article is sponsored by Revvity. By Anis H Khimani, PhD, Senior Strategy Leader, Life Sciences strategy group, Revvity, Inc. Across the biotherapeutics workflow The landscape of large molecule drug development has evolved significantly in recent decades. As the significance of large molecules… Read More

#Exclusive Content

Target concept
#Biopharma #Covid-19 #Drug discovery

The value of mission-orientated research in biopharma R&D 

Patrick Speedie, Co-Founder & Co-CEO of IN-PART, explores why a global approach is needed for the best science to prosper and the lessons industry can take from the Covid-19 pandemic.    The Covid-19 pandemic unequivocally demonstrated the power of industry-academia collaboration, with the fastest ever… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Big pharma #BioNTech #Biopharmaceuticals #Comirnaty #Covid-19 #Drug discovery #Healthcare #Moderna #mRNA #Pfizer

New podcast on drug discovery trends

This is the latest episode of the free DDW narrated podcast, “Drug discovery trends: From regulation to embracing AI”, which covers two articles written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: From the Editor: Law and order and… Read More

#News

#AI #Biotech #Drug discovery #Generative AI

Genentech and NVIDIA partner to accelerate drug discovery with AI 

Biotechnology company Genentech has entered into a partnership with software group NVIDIA to use generative AI to discover and develop new therapeutics.   The collaboration will see experts from each company optimise and accelerate Genentech’s proprietary algorithms with goals to transform the discovery and development of new… Read More

#News

#Drug discovery #Lab space #UK #UK economy

Lack of lab space hindering growth in the UK, report finds  

The UK must build more laboratory space if it is to meet its global ambitions of becoming a scientific leader, property firms and estate agencies have argued.  A report published by British Land and Savills states that there is a severe shortage of laboratory space to meet… Read More

#News

#Alzheimer's #Drug discovery #Neurology #Stem cells

bit.bio launches stem cell line for neuro research and screening  

Biotechnology company bit.bio has launched a range of immune cells to provide researchers with a consistently functional and rapid human in vitro model for the study of neuroinflammation and neurodegenerative diseases.  The company’s ioMicroglia cell range is designed to recapitulate key human microglia functions and… Read More

#News

#CAR-T #Cell and gene therapy #Cell therapy #CRISPR #Drug discovery #Gene therapy

New DDW Highlights podcast: 20 November 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The breaking news this week was certainly the first regulatory approval for… Read More

#News

#DNA #Drug discovery #Synthetic biology

Unlocking the potential of synthetic DNA 

Raquel Sanches-Kuiper, Vice President of Science and Applications at Evonetix, and Clare Whitewoods, Marketing Communications Manager at Evonetix, look at the benefits synthetic DNA brings to pharmaceutical development.  Engineering biology is reshaping the world, from enabling the rapid development of vaccines to providing alternatives to petroleum… Read More

#Exclusive Content